Funded Tech Companies
Ocugen
Wondering who invested in Ocugen? Private investors, Abdi Ibrahim and EB5 Life Sciences joined the equity holders in this innovative biopharmaceutical company.
Company Overview
Company Name
Ocugen
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
5 Great Valley Pkwy. 160
Malvern, PA 19355
USA
Malvern, PA 19355
USA
Phone
Website
Email Address
Not Recorded
Company Background Information
Overview
Ocugen is advancing two novel biologicals and a marketed drug product as a re-purposed drug under the U.S. Food and Drug Administration's 505(b)(2) regulatory pathway to treat sight threatening ocular disorders.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
2/16/2018
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Shankar Musunuri
Chief Financial Officer
Sanjay Subramanian
Chief Medical Officer
Mohamed Genead
Chief Scientific Officer
Rasappa Arumugham
Controller
Jessica Crespo
VP - Regulatory Affairs
Vijay Tammara
Company Investors
- Abdi Ibrahim (Nezih Barut)
- Private Investors (Frank Leo)
- Private Investors (John Zhang)
- EB5 Life Sciences
- Global City Regional Center
- Private Investors (Bernhard Hampl)
Browse more funded tech companies:
Share this article
About Our VC Deals Database
The company data above is provided by VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs